ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 38 filers reported holding ADC THERAPEUTICS SA in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 5,402,041 | $4,845,631 | 1.54% |
Sio Capital Management, LLC | 3,294,534 | $2,955,197 | 0.92% |
Redmile Group, LLC | 14,178,045 | $12,717,706 | 0.60% |
AlphaCentric Advisors LLC | 1,068,468 | $958,416 | 0.54% |
Vantage Consulting Group Inc | 850,737 | $763,111 | 0.51% |
Blue Owl Capital Holdings LP | 733,568 | $654,489 | 0.51% |
Affinity Asset Advisors, LLC | 1,100,000 | $986,700 | 0.28% |
Frazier Life Sciences Management, L.P. | 1,647,030 | $1,477,386 | 0.10% |
Indie Asset Partners, LLC | 92,700 | $83,152 | 0.08% |
GCM Grosvenor Holdings, LLC | 410,888 | $368,567 | 0.07% |